POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 102 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $149,686 | +48.1% | 62,893 | +9.5% | 0.00% | – |
| Q2 2023 | $101,085 | +1584.8% | 57,435 | +3183.9% | 0.00% | – |
| Q1 2023 | $6,000 | +3536.4% | 1,749 | -94.4% | 0.00% | – |
| Q4 2022 | $165 | -100.0% | 31,224 | -72.4% | 0.00% | – |
| Q3 2022 | $400,000 | -33.8% | 113,187 | -51.7% | 0.00% | – |
| Q2 2022 | $604,000 | -57.7% | 234,184 | -26.5% | 0.00% | – |
| Q1 2022 | $1,428,000 | -29.6% | 318,676 | +7.0% | 0.00% | – |
| Q4 2021 | $2,027,000 | -21.5% | 297,782 | -15.9% | 0.00% | – |
| Q3 2021 | $2,581,000 | -17.6% | 354,065 | +13.2% | 0.00% | – |
| Q2 2021 | $3,134,000 | +5.6% | 312,694 | +0.6% | 0.00% | – |
| Q1 2021 | $2,969,000 | +4467.7% | 310,862 | +5129.0% | 0.00% | – |
| Q4 2020 | $65,000 | +44.4% | 5,945 | +18.8% | 0.00% | – |
| Q3 2020 | $45,000 | – | 5,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |